56671-28-4

Basic information

• Product Name: 4-OXO-4,5,6,7-TETRAHYDROBENZO[B]FURAN-3-CARBOXYLIC ACID
• Synonyms: 4,5,6,7-tetrahydro-4-oxo-3-benzofurancarboxylicacid;IFLAB-BB F1901-0074;BUTTPARK 29\08-32;4-OXO-4,5,6,7-TETRAHYDRO-1-BENZOFURAN-3-CARBOXYLIC ACID;4-OXO-4,5,6,7-TETRAHYDROBENZO[B]FURAN-3-CARBOXYLIC ACID;4-OXO-4,5,6,7-TETRAHYDROBENZOFURAN-3-CARBOXYLIC ACID;4-OXO-4,5,6,7-TETRAHYDROCOUMARONE-3-CARBOXYLIC ACID;AKOS BBS-00000134
• CAS NO: 56671-28-4
• Molecular Formula: C₉H₈O₄
• Molecular Weight: 180.16
• Mol File: 56671-28-4.mol
• Article Data: 9

Chemical Properties

• Melting Point: 140 °C
• Boiling Point: 383.5 °C at 760 mmHg
• Flash Point: 185.7 °C
• Appearance: /
• Density: 1.406 g/cm³
• Vapor Pressure: 1.44E-06mmHg at 25°C
• Refractive Index: 1.576
• Storage Temp.: 2-8°C
• PKA: 3.74±0.20(Predicted)
• CAS DataBase Reference: 4-OXO-4,5,6,7-TETRAHYDROBENZO[B]FURAN-3-CARBOXYLIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: 4-OXO-4,5,6,7-TETRAHYDROBENZO[B]FURAN-3-CARBOXYLIC ACID(56671-28-4)
• EPA Substance Registry System: 4-OXO-4,5,6,7-TETRAHYDROBENZO[B]FURAN-3-CARBOXYLIC ACID(56671-28-4)

Safety Data

• Hazard Codes: C
• Statements: 36/37/38
• Safety Statements: 26-36/37/39
• HazardClass: IRRITANT
• Hazardous Substances Data: 56671-28-4(Hazardous Substances Data)

Usage

General Description

4-Oxo-4,5,6,7-tetrahydrobenzo[b]furan-3-carboxylic Acid is a chemical compound with a complex structure featuring a heterocyclic furan ring. It is an organic compound categorized under the tetrahydrobenzofurans family. 4-OXO-4,5,6,7-TETRAHYDROBENZO[B]FURAN-3-CARBOXYLIC ACID is of interest in the field of chemistry due to its unique structure and potential applications. Properties or applications of this particular chemical are not well-documented or specific, which is common with complex, specialized compounds like this one. Thus, more experimental research is needed to fully explore its potential in various fields such as pharmaceuticals, materials science, or others.

InChI:InChI=1/C9H8O4/c10-6-2-1-3-7-8(6)5(4-13-7)9(11)12/h4H,1-3H2,(H,11,12)

Upstream product

• 70-23-5 ethyl Bromopyruvate 
• 504-02-9 1,3-cylohexanedione 
• 765-87-7 cyclohexane-1,2-dione 
• 1113-59-3 bromopyruvic acid 
• 128428-59-1 3-hydroxy-4-oxo-2,3,4,5,6,7-hexahydrobenzofuran-3-carboxylic acid ethyl ester 

Downstream Products

• 13618-91-2 4,5,6,7-tetrahydroindole 
• 13754-86-4 1,5,6,7-tetrahydro-indol-4-one 
• 112678-09-8 3-carboxy-4-hydroxybenzo-(b)-furan 
• 82584-78-9 4-oxo-4,5,6,7-tetrahydrobenzofuran-3-carboxylic acid methyl ester 
• 23922-57-8 N-cyclohexyl-4-oxo-4,5,6,7-tetrahydroindole 
• 213183-59-6 C₁₅H₁₅NO₂ 
• 1006872-07-6 6,7-dihydro-1-phenethyl-1H-indol-4(5H)-one 
• 23870-03-3 1-phenyl-1,5,6,7-tetrahydro-indol-4-one 
• 13671-74-4 1-benzyl-4-oxo-4,5,6,7-tetrahydroindole 
• 1044257-88-6 ethyl 2-(4,5,6,7-tetrahydro-4-oxoindol-1-yl)-3-phenylpropanoate 
• 180339-31-5 (Z)-4,5,6,7-Tetrahydro-4-(hydroxyimino)-3-benzofurancarboxylic acid 
• 121661-49-2 2-(2-Diethylamino-ethyl)-5-phenyl-5,6,7,8-tetrahydro-2H-pyrrolo[4,3,2-de]cinnolin-3-one 
• 121625-85-2 2-(3-Dimethylamino-propyl)-5-phenyl-5,6,7,8-tetrahydro-2H-pyrrolo[4,3,2-de]cinnolin-3-one 
• 121625-84-1 5-Phenyl-5,6,7,8-tetrahydro-2H-pyrrolo[4,3,2-de]cinnolin-3-one 

Relevant articles and documents

4-oxa-4,5,6,7-tetrahydro benzo[B] furan-3-carboxylic compound and application thereof

The invention discloses a 4-oxa-4,5,6,7-tetrahydro benzo[B] furan-3-carboxylic compound which is of a structure as shown in the formula I. A preparation method of the 4-oxa-4,5,6,7-tetrahydro benzo[B] furan-3-carboxylic compound is quick, convenient and l

NOVEL TRICYCLIC CALCIUM SENSING RECEPTOR ANTAGONISTS FOR THE TREATMENT OF OSTEOPOROSIS

Novel tricyclic compounds of the formula (I): and pharmaceutically acceptable salts thereof are disclosed as useful for treating or preventing osteoporosis and similar conditions. The compounds are effective as calcium sensing receptor antagonists. Pharmaceutical compositions and methods of treatment are also included.

Fused pyrrolecarboxamides: GABA brain receptor ligands

Substituted pyrrolecarboxamide compounds are disclosed. These compounds are highly selective agonists, antagonists or inverse agonists for GABAA brain receptors or prodrugs of agonists, antagonists or inverse agonists for GABAA brain receptors and are therefore useful in the diagnosis and treatment of anxiety, depression, Alzheimer's dementia, sleep and seizure disorders, overdose with benzodiazepine drugs and for enhancement of memory. Pharmaceutical compositions, including packaged pharmaceutical compositions, are further provided. Compounds of the invention are also useful as probes for the localization of GABAA receptors in tissue samples.